Disease/Infection News

RSS

Obesity-related cancers take a toll in Southern Africa: Study reveals alarming trends

Research analyzes the prevalence and mortality rates of obesity-related cancers in 16 Southern African countries. It identifies leukemia, esophageal cancer, and colon/rectum cancer as leading causes of cancer mortality in males, and breast cancer, leukemia, and esophageal cancer in females.

29 May 2023

Study maps immune responses produced by COVID-19 vaccination in First Nations population

Published in Nature Immunology and Nature Briefing, the research is the first of its kind to decisively map immune responses produced by a COVID-19 vaccination in any First Nations populations.

29 May 2023

MHRA authorizes new COVID-19 vaccine from SK Chemicals

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified genes for virulence and antimicrobial resistance in two bacteria that co-occur with C. difficile, suggesting these pathogens as emerging potential threats in planetary health.

26 May 2023

Is a multicomponent hypertension management program implemented in the public primary care setting associated with fewer patient complications and mortality?

Researchers compared hypertension-associated complications and the use of healthcare services at five years among hypertensive individuals managed using the Risk Assessment and Management Program for Hypertension (RAMP-HT) versus regular care.

26 May 2023

Insights into the direction and extent of gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment

Researchers performed a meta-analysis to determine the association between intestinal microbiota and Alzheimer’s disease (AD).

26 May 2023

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2.

26 May 2023

Associations between exposure to air pollution and severe COVID-19

Researchers explored associations between prolonged exposure to air pollution and severe coronavirus disease 2019.

26 May 2023

How do the outcomes of viral coinfections vary across host species?

In a recent study published in the journal PLOS Pathogens, researchers investigated the outcomes of coinfections of two viruses — Drosophila C Virus (DCV) and Cricket Paralysis Virus (CrPV) in 25 inbred lines of Drosophila melanogaster and 47 other host species belonging to the Drosophilidae family.

26 May 2023

New review unravels phthalates’ role in heart disease

Researchers review existing data on the impact of phthalate exposure on cardiovascular health.

25 May 2023

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

Researchers develop a lipid nanoparticle-formulated mRNA-based antigen encoding three SARS-CoV-2 peptides derived from non-structural proteins.

25 May 2023

Adoption of Mediterranean diet shows promise in easing symptoms for myeloproliferative neoplasm patients

Researchers assess the feasibility of an education-focused Mediterranean diet intervention among myeloproliferative neoplasm patients.

25 May 2023

Novel vaccine offers hope for defeating epidemic meningitis by 2030

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal bacteria: A, C, W, Y and X.

25 May 2023

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

25 May 2023

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant.

25 May 2023

Immune cells targeting core protein play an important role in early immune defense against COVID-19

LMU immunologists have studied the early immune response to acute SARS-CoV-2 infection and show how vaccines could be improved in future.

25 May 2023

Study elucidates 12 defining symptoms of long COVID

Long COVID, or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), includes a wide range of symptoms that present or persist more than 30 days after COVID-19 infection.

25 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

Exercise capacity found to be lower than expected among people with long COVID

While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

25 May 2023

Disease/Infection News

Obesity-related cancers take a toll in Southern Africa: Study reveals alarming trends

Study maps immune responses produced by COVID-19 vaccination in First Nations population

MHRA authorizes new COVID-19 vaccine from SK Chemicals

Large study uncovers new details about long COVID

Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

Is a multicomponent hypertension management program implemented in the public primary care setting associated with fewer patient complications and mortality?

Insights into the direction and extent of gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

Associations between exposure to air pollution and severe COVID-19

How do the outcomes of viral coinfections vary across host species?

New review unravels phthalates’ role in heart disease

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

Adoption of Mediterranean diet shows promise in easing symptoms for myeloproliferative neoplasm patients

Novel vaccine offers hope for defeating epidemic meningitis by 2030

RECOVER study: An important step toward defining long COVID

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

Immune cells targeting core protein play an important role in early immune defense against COVID-19

Study elucidates 12 defining symptoms of long COVID

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Exercise capacity found to be lower than expected among people with long COVID

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News